{"id":"W2953630757","doi":"10.1016/j.jsxm.2019.05.012","title":"Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide","year":2019,"lang":"en","type":"article","venue":"The Journal of Sexual Medicine","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Janssen Biotech; Sage Therapeutics; Alkermes; Covis Pharma; Ministerul Cercetării, Inovării şi Digitalizării; Valeant Pharmaceuticals International","keywords":"Hypoactive sexual desire disorder; Dose-ranging study; Female sexual dysfunction; Medicine; Receiver operating characteristic; Orgasm; Sexual function; Minimal clinically important difference; Sexual desire; Distress; Sexual dysfunction; Internal medicine; Psychology; Clinical psychology; Randomized controlled trial; Placebo; Human sexuality; Double blind; Pathology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02771433,0.001217841,0.001745487,0.000778702,0.0007434853,0.000851689,0.0006041963,0.001356907,0.004909595],"category_scores_gemma":[0.01722793,0.000480485,0.002136045,0.0005181824,0.0008179289,0.0009651433,0.0007614589,0.00281238,0.0007474099],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004734514,"about_ca_system_score_gemma":0.001038323,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001870417,"about_ca_topic_score_gemma":0.0003281172,"domain_scores_codex":[0.9878531,0.008544537,0.0008481051,0.0008478006,0.001560361,0.0003461772],"domain_scores_gemma":[0.9844848,0.008629813,0.002827307,0.002179652,0.00121604,0.0006623649],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7752079,0.03634965,0.03927168,0.001393897,0.006077339,0.0002850979,0.0008442528,0.003451343,0.04527564,0.0004981812,0.004772925,0.0865721],"study_design_scores_gemma":[0.2355927,0.6028375,0.1292159,0.00009106871,0.003364426,0.0006119795,0.0001638826,0.003223342,0.01711032,0.0009901884,0.00667807,0.0001205383],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9685172,0.001664253,0.008460851,0.0003158646,0.0001632487,0.0133615,0.003954659,0.0002981303,0.003264246],"genre_scores_gemma":[0.9640799,0.0003966402,0.01139517,0.001064077,0.0002211372,0.01685834,0.003273594,0.0001368238,0.002574353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02771433,"threshold_uncertainty_score":0.1465691,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1570862730073383,"score_gpt":0.4381977896091684,"score_spread":0.2811115166018301,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}